Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PELI2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | IDH2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | TCERG1L | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | PPFIA2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | MAU2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | PGBD5 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | CXorf21 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | ZNF362 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | CHN2 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | GMIP | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-06 |